Company Filing History:
Years Active: 2021-2025
Title: The Innovations of Laurence David Sibley
Introduction
Laurence David Sibley is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of parasitology through his innovative research and development of compounds aimed at treating parasitic diseases. With a total of 5 patents, Sibley's work has had a profound impact on medical science.
Latest Patents
Sibley's latest patents include groundbreaking advancements in the treatment of parasitic diseases. One of his notable inventions is a patent for "Compounds and methods for the treatment of parasitic diseases." This patent provides compounds that are useful for treating various parasitic diseases, including cryptosporidiosis. These compounds can be formulated into pharmaceutical and veterinary compositions for effective treatment and prophylaxis. Another significant patent is for "Antigens for detecting toxoplasma infection by monitoring cellular immunity." This invention utilizes specific antigens that elicit a strong delayed type hypersensitivity immune response, which can be used to test for infections. The presence of delayed type hypersensitivity indicates infection, and alternate methods for detecting T cell responses are also included in this patent.
Career Highlights
Throughout his career, Sibley has worked with prestigious institutions such as Washington University and the University of California. His research has focused on developing innovative solutions to combat parasitic infections, showcasing his dedication to improving public health.
Collaborations
Sibley has collaborated with talented individuals in his field, including Iti Saraav and Qiuling Wang. These collaborations have further enhanced his research and contributed to the success of his inventions.
Conclusion
Laurence David Sibley is a distinguished inventor whose work in the treatment of parasitic diseases has led to significant advancements in medical science. His innovative patents and collaborations reflect his commitment to improving health outcomes for individuals affected by these diseases.